New MMA methodology for drug prices is a big change for many payers

As we move into 2005, injectable industry stakeholders-including payers, providers, manufacturers and regulators-are evaluating the impact of the Medicare Modernization Act (MMA) on their business practices.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.